KMT2A and prostate carcinoma: DOT1L catalyzes the mono-, di- and trimethylation of Histone H3 on Lysine-79 (K79); it is involved in different biological processes, such as DNA repair, transcriptional elongation and cell cycle progression and its enrollment in cancer progression has been widely demonstrated in different types of cancers, such as in mixed-lineage leukemia (MLL) in which participates in producing MLL fusion proteins, sustaining leukemogenesis processes [104], prostate cancer [105] and ovarian cancer [106].